By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Veloxis Pharmaceuticals A/S 

Kogle Allé 4

  DK-2970  Hørsholm  Denmark
Phone: 457-033-3300 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
U.S. District Court Sets Briefing Schedule In Veloxis Pharmaceuticals A/S (VELO) Litigation 1/15/2015 8:16:02 AM
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015 7:26:26 AM
Veloxis Pharmaceuticals A/S (VELO) Comments On U.S. District Court Order 12/19/2014 9:44:55 AM
Veloxis Pharmaceuticals A/S (VELO) Announces That It Has Filed An Action Against The FDA, Seeking An Order Requiring FDA To Grant Final Approval To Envarsus XR 12/17/2014 9:47:23 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Publication Of Phase 3 Study Of Once Daily Envarsus® XR Demonstrating Non-Inferiority Vs. Twice-Daily Tacrolimus In De Novo Kidney Transplant Patients 11/17/2014 10:14:16 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014 10:04:20 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR 10/31/2014 8:17:37 AM
Veloxis Pharmaceuticals A/S (VELO) Is Implementing Cegedim Relationship Management Mobile Intelligence CRM And Support Services To Empower Diverse Field Users 10/15/2014 1:43:16 PM
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Six Months Of 2014 8/21/2014 7:56:07 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® Receives European Marketing Authorization For Treatment Of Both Kidney And Liver Transplant Patients 7/28/2014 7:44:37 AM
12345678
//-->